Compare $AEON vs $LTRN | Chartloom

Compare

$AEON vs $LTRN

AEON Biopharma Inc · Lantern Pharma Inc

AEON

AEON Biopharma Inc

LTRN

Lantern Pharma Inc

Compare $AEON vs $LTRN

Comparing AEON Biopharma Inc and Lantern Pharma Inc

AEONAEON Biopharma Inc

LTRNLantern Pharma Inc

AEONAEON Biopharma Inc

Market cap

$10M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-75.1%

52W performance

-70.0%

FCF yield

-133.0%

LTRNLantern Pharma Inc

Market cap

$10M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-73.9%

52W performance

-82.3%

FCF yield

-135.8%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

AEON

LTRN

Detailed metrics comparison

AEON

AEON Biopharma Inc

LTRN

Lantern Pharma Inc

Market Cap

AEON$10M

LTRN$10M

Enterprise Value

AEON$9M

LTRN$4M

Price

AEON$0.28

LTRN$0.81

P/E Ratio

AEONN/A

LTRNN/A

P/S Ratio

AEON0.00x

LTRN0.00x

EV/Sales

AEON0.00x

LTRN0.00x

EV/EBITDA

AEON0.08x

LTRN0.00x

P/B Ratio

AEON4.90x

LTRN3.19x

P/FCF Ratio

AEONN/A

LTRNN/A

EV/FCF

AEON-0.63x

LTRN-0.26x

PEG Ratio

AEONN/A

LTRNN/A

Forward P/E (NTM)

AEONN/A

LTRNN/A

Forward P/S (NTM)

AEONN/A

LTRNN/A

Revenue (TTM)

AEON$0

LTRN$0

Revenue Growth (YoY)

AEONN/A

LTRNN/A

Forward Rev Growth

AEON3564.8%

LTRN0.0%

Gross Margin (TTM)

AEON0.0%

LTRN0.0%

Operating Margin (TTM)

AEON0.0%

LTRN0.0%

EBITDA Margin (TTM)

AEON0.0%

LTRN0.0%

Net Margin (TTM)

AEON0.0%

LTRN0.0%

FCF Margin (TTM)

AEONN/A

LTRNN/A

Net Income (TTM)

AEON$-55M

LTRN$-19M

FCF (TTM)

AEON$-14M

LTRN$-14M

EPS (TTM)

AEON-$1.08

LTRN-$1.50

ROE (TTM)

AEON-174.1%

LTRN-19835.0%

ROA (TTM)

AEON-75776.0%

LTRN-18428.0%

ROIC (TTM)

AEON-180.4%

LTRN-19835.0%

Cash

AEON$3M

LTRN$7M

Debt

AEON$2M

LTRN$0

Net Cash/Debt

AEON$2M

LTRN$7M

Current Ratio (TTM)

AEON0.54x

LTRN1.96x

Quick Ratio (TTM)

AEON0.47x

LTRN1.70x

Debt/Equity (TTM)

AEON10.28x

LTRN0.00x

Debt/Assets (TTM)

AEON0.0%

LTRN0.0%

Interest Coverage (TTM)

AEONN/A

LTRNN/A

Net Debt/EBITDA (TTM)

AEON0.00x

LTRN0.00x

Beta

AEON0.64

LTRN2.42

52W Performance

AEON-70.0%

LTRN-82.3%

YTD Performance

AEON-75.1%

LTRN-73.9%

% from 52W High

AEON-81.0%

LTRN-82.7%

% from 52W Low

AEON55.8%

LTRN6.9%

Asset Turnover (TTM)

AEON0.00x

LTRN0.00x

FCF Yield (TTM)

AEON-133.0%

LTRN-135.8%

Earnings Yield (TTM)

AEON-532.7%

LTRN-179.9%

Dividend Yield (TTM)

AEONN/A

LTRNN/A

Rule of 40

AEON0.0

LTRN0.0

EV/GP/RG

AEONN/A

LTRNN/A

Ticker research

View AEON research View LTRN research

Metric	AEON AEON Biopharma Inc	LTRN Lantern Pharma Inc
Market & Valuation
Market Cap	$10M	$10M
Enterprise Value	$9M	$4M
Price	$0.28	$0.81
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.08x	0.00x
P/B Ratio	4.90x	3.19x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.63x	-0.26x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	3564.8%	0.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-55M	$-19M
FCF (TTM)	$-14M	$-14M
EPS (TTM)	-$1.08	-$1.50
ROE (TTM)	-174.1%	-19835.0%
ROA (TTM)	-75776.0%	-18428.0%
ROIC (TTM)	-180.4%	-19835.0%
Financial Health
Cash	$3M	$7M
Debt	$2M	$0
Net Cash/Debt	$2M	$7M
Current Ratio (TTM)	0.54x	1.96x
Quick Ratio (TTM)	0.47x	1.70x
Debt/Equity (TTM)	10.28x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.64	2.42
52W Performance	-70.0%	-82.3%
YTD Performance	-75.1%	-73.9%
% from 52W High	-81.0%	-82.7%
% from 52W Low	55.8%	6.9%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-133.0%	-135.8%
Earnings Yield (TTM)	-532.7%	-179.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View AEON research	View LTRN research

Valuation

P/S Ratio

AEON

0.00x

LTRN

0.00x

EV/FCF

AEON

-0.63x

LTRN

-0.26x

Growth & revenue

Forward Revenue Growth

AEON

3564.8%

LTRN

0.0%

Profitability & performance

Gross Margin

AEON

0.0%

LTRN

0.0%

ROE

AEON

-174.1%

LTRN

-19835.0%

FCF Yield %

AEON

-133.0%

LTRN

-135.8%

52-Week Performance

AEON

-70.0%

LTRN

-82.3%

Detailed metrics comparison

AEON

AEON Biopharma Inc

LTRN

Lantern Pharma Inc

Market Cap

AEON$10M

LTRN$10M

Enterprise Value

AEON$9M

LTRN$4M

Price

AEON$0.28

LTRN$0.81

P/E Ratio

AEONN/A

LTRNN/A

P/S Ratio

AEON0.00x

LTRN0.00x

EV/Sales

AEON0.00x

LTRN0.00x

EV/EBITDA

AEON0.08x

LTRN0.00x

P/B Ratio

AEON4.90x

LTRN3.19x

P/FCF Ratio

AEONN/A

LTRNN/A

EV/FCF

AEON-0.63x

LTRN-0.26x

PEG Ratio

AEONN/A

LTRNN/A

Forward P/E (NTM)

AEONN/A

LTRNN/A

Forward P/S (NTM)

AEONN/A

LTRNN/A

Revenue (TTM)

AEON$0

LTRN$0

Revenue Growth (YoY)

AEONN/A

LTRNN/A

Forward Rev Growth

AEON3564.8%

LTRN0.0%

Gross Margin (TTM)

AEON0.0%

LTRN0.0%

Operating Margin (TTM)

AEON0.0%

LTRN0.0%

EBITDA Margin (TTM)

AEON0.0%

LTRN0.0%

Net Margin (TTM)

AEON0.0%

LTRN0.0%

FCF Margin (TTM)

AEONN/A

LTRNN/A

Net Income (TTM)

AEON$-55M

LTRN$-19M

FCF (TTM)

AEON$-14M

LTRN$-14M

EPS (TTM)

AEON-$1.08

LTRN-$1.50

ROE (TTM)

AEON-174.1%

LTRN-19835.0%

ROA (TTM)

AEON-75776.0%

LTRN-18428.0%

ROIC (TTM)

AEON-180.4%

LTRN-19835.0%

Cash

AEON$3M

LTRN$7M

Debt

AEON$2M

LTRN$0

Net Cash/Debt

AEON$2M

LTRN$7M

Current Ratio (TTM)

AEON0.54x

LTRN1.96x

Quick Ratio (TTM)

AEON0.47x

LTRN1.70x

Debt/Equity (TTM)

AEON10.28x

LTRN0.00x

Debt/Assets (TTM)

AEON0.0%

LTRN0.0%

Interest Coverage (TTM)

AEONN/A

LTRNN/A

Net Debt/EBITDA (TTM)

AEON0.00x

LTRN0.00x

Beta

AEON0.64

LTRN2.42

52W Performance

AEON-70.0%

LTRN-82.3%

YTD Performance

AEON-75.1%

LTRN-73.9%

% from 52W High

AEON-81.0%

LTRN-82.7%

% from 52W Low

AEON55.8%

LTRN6.9%

Asset Turnover (TTM)

AEON0.00x

LTRN0.00x

FCF Yield (TTM)

AEON-133.0%

LTRN-135.8%

Earnings Yield (TTM)

AEON-532.7%

LTRN-179.9%

Dividend Yield (TTM)

AEONN/A

LTRNN/A

Rule of 40

AEON0.0

LTRN0.0

EV/GP/RG

AEONN/A

LTRNN/A

Ticker research

View AEON research View LTRN research

Metric	AEON AEON Biopharma Inc	LTRN Lantern Pharma Inc
Market & Valuation
Market Cap	$10M	$10M
Enterprise Value	$9M	$4M
Price	$0.28	$0.81
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.08x	0.00x
P/B Ratio	4.90x	3.19x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.63x	-0.26x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	3564.8%	0.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-55M	$-19M
FCF (TTM)	$-14M	$-14M
EPS (TTM)	-$1.08	-$1.50
ROE (TTM)	-174.1%	-19835.0%
ROA (TTM)	-75776.0%	-18428.0%
ROIC (TTM)	-180.4%	-19835.0%
Financial Health
Cash	$3M	$7M
Debt	$2M	$0
Net Cash/Debt	$2M	$7M
Current Ratio (TTM)	0.54x	1.96x
Quick Ratio (TTM)	0.47x	1.70x
Debt/Equity (TTM)	10.28x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.64	2.42
52W Performance	-70.0%	-82.3%
YTD Performance	-75.1%	-73.9%
% from 52W High	-81.0%	-82.7%
% from 52W Low	55.8%	6.9%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-133.0%	-135.8%
Earnings Yield (TTM)	-532.7%	-179.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View AEON research	View LTRN research